Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function
Zoe Arvanitakis, Hoau‐Yan Wang, Ana W. Capuano, et al.
Annals of Neurology (2020) Vol. 88, Iss. 3, pp. 513-525
Open Access | Times Cited: 82

Showing 26-50 of 82 citing articles:

Associations of Serum Insulin and Related Measures With Neuropathology and Cognition in Older Persons With and Without Diabetes
Zoe Arvanitakis, Ana W. Capuano, Han Tong, et al.
Annals of Neurology (2024) Vol. 95, Iss. 4, pp. 665-676
Closed Access | Times Cited: 6
Lower GLUT1 and unchanged MCT1 in Alzheimer’s disease cerebrovasculature
Manon Leclerc, Cyntia Tremblay, Philippe Bourassa, et al.
Journal of Cerebral Blood Flow & Metabolism (2024) Vol. 44, Iss. 8, pp. 1417-1432
Open Access | Times Cited: 6
Network pharmacology to unveil the mechanism of suanzaoren decoction in the treatment of alzheimer’s with diabetes
Tao Chen, Yining Lei, Manqin Li, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access | Times Cited: 5
The role of traditional Chinese medicine in the treatment of cognitive dysfunction in type 2 diabetes
Jinni Meng, Yafei Zhu, Huixia Ma, et al.
Journal of Ethnopharmacology (2021) Vol. 280, pp. 114464-114464
Closed Access | Times Cited: 28
Brain insulin resistance and cognitive function: influence of exercise
Steven K. Malin, Nathan R. Stewart, Andrew A. Ude, et al.
Journal of Applied Physiology (2022) Vol. 133, Iss. 6, pp. 1368-1380
Open Access | Times Cited: 21
Brain Insulin Signaling is Associated with Late-Life Cognitive Decline
Han Tong, Ana W. Capuano, Owen Carmichael, et al.
Aging and Disease (2024) Vol. 15, Iss. 5, pp. 2205-2205
Open Access | Times Cited: 4
Exploiting Common Aspects of Obesity and Alzheimer’s Disease
Sidra Tabassum, Afzal Misrani, Li Yang
Frontiers in Human Neuroscience (2020) Vol. 14
Open Access | Times Cited: 28
Metabolic determinants of Alzheimer’s disease: A focus on thermoregulation
Marine Tournissac, Manon Leclerc, Josue Valentin‐Escalera, et al.
Ageing Research Reviews (2021) Vol. 72, pp. 101462-101462
Closed Access | Times Cited: 27
Analysis of the Molecular Mechanism of Punicalagin in the Treatment of Alzheimer’s Disease by Computer-Aided Drug Research Technology
Ping Xu, Liang Xu, Shuyun Huang, et al.
ACS Omega (2022) Vol. 7, Iss. 7, pp. 6121-6132
Open Access | Times Cited: 17
Alterations of amino acids in older adults with Alzheimer’s Disease and Vascular Dementia
Xin Ma, Xin-Meng Wang, Guozhang Tang, et al.
Amino Acids (2025) Vol. 57, Iss. 1
Open Access
Circulating Non-esterified Fatty Acids, Risk of Dementia and Cognitive Decline: The Cardiovascular Health Study and Multi-Ethnic Study of Atherosclerosis
Kristine F. Moseholm, Majken K. Jensen, Petra Bůžková, et al.
Neurobiology of Aging (2025) Vol. 148, pp. 71-79
Closed Access
A systematic review of in vivo brain insulin resistance biomarkers in humans
Graham Reid, Brendan Sargent, Sarah Bauermeister, et al.
Biomarkers in Neuropsychiatry (2025), pp. 100125-100125
Open Access
Alzheimer's disease-related cortical proteins modify the association of brain insulin signaling with cognitive decline
Han Tong, Vladislav Petyuk, Michael Sendtner, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Target Validation Studies of PS48, a PDK-1 Allosteric Agonist, for the Treatment of Alzheimer’s Disease Phenotype in APP/PS1 Transgenic Mice
Henry Querfurth, Cynthia A. Lemere, Jason Ciola, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3473-3473
Open Access
Polyoxometalates as effective inhibitors of insulin amyloid fibrils: a promising therapeutic avenue
Ashim Jyoti Bharati, Ritu Zende, Manash J. Deka, et al.
Journal of Biomolecular Structure and Dynamics (2025), pp. 1-8
Closed Access
Induction of Brain Insulin Resistance and Alzheimer’s Molecular Changes by Western Diet
Anna Mietelska‐Porowska, Justyna Marta Domańska, Andrew Want, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4744-4744
Open Access | Times Cited: 15
Endothelial Dysfunctions in Blood–Brain Barrier Breakdown in Alzheimer's Disease: From Mechanisms to Potential Therapies
Qian Yue, Xuebing Leng, Na Xie, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 11
Open Access | Times Cited: 3
Targeting the renin angiotensin system for the treatment of anxiety and depression
Sophocles Chrissobolis, Anh Luu, R. Waldschmidt, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 199, pp. 173063-173063
Closed Access | Times Cited: 22
Mitochondrial dysfunction: A potential target for Alzheimer’s disease intervention and treatment
Jia Ke, Qinfang Tian, Qixia Xu, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 8, pp. 1991-2002
Closed Access | Times Cited: 20
Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome
Alessandra Cadete Martini, Thomas Groß, Elizabeth Head, et al.
Neuron (2022) Vol. 110, Iss. 13, pp. 2063-2079
Open Access | Times Cited: 14
Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer’s Disease
Alana V. Beadell, Zhou Zhang, Ana W. Capuano, et al.
Journal of Alzheimer s Disease (2023) Vol. 93, Iss. 3, pp. 1135-1151
Open Access | Times Cited: 7
Associations of renin–angiotensin system inhibitor use with brain insulin signaling and neuropathology
Han Tong, Ana W. Capuano, Rupal I. Mehta, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 8, pp. 2112-2122
Open Access | Times Cited: 2
Prevalence of mild cognitive impairment and modifiable risk factors: A cross-sectional study in rural older adults with diabetes
Xueyan Liu, Tianshu Jiang, Yuanyuan Jiang, et al.
Geriatric Nursing (2024) Vol. 59, pp. 549-556
Closed Access | Times Cited: 2
From Plaques to Pathways in Alzheimer’s Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis
Sarah Kazemeini, Ahmed Nadeem-Tariq, Ryan M. Shih, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11720-11720
Open Access | Times Cited: 2
Brain insulin signaling and cerebrovascular disease in human postmortem brain
Zoe Arvanitakis, Ana W. Capuano, Hoau-Yan Wang, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 15

Scroll to top